Academic Radiation Oncologist/Faculty Rank DOQ

University of Nebraska Medical CenterOmaha, NE
Onsite

About The Position

The University of Nebraska Medical Center (UNMC), Department of Radiation Oncology at the NCI-designated Fred & Pamela Buffett Cancer Center, in partnership with Nebraska Medicine, is seeking a Radiation Oncologist with a primary clinical focus in Head and Neck Oncology and a negotiable secondary focus. This is an exceptional opportunity to join a dynamic academic department. The Fred & Pamela Buffett Cancer Center is Nebraska’s only NCI-designated cancer center, serving as the hub for clinical, research, and education activities. The department is expanding and includes twelve physicians, eleven physicists, and research faculty and staff. The department will feature the only proton therapy capability in the state of Nebraska and the region, including Flash research capability. The position offers access to state-of-the-art treatment facilities, advanced radiation therapy technologies, and robust support from a highly skilled team. Applications are welcomed from both experienced clinicians and recent graduates.

Requirements

  • MD or DO degree (or equivalent degree).
  • Board certified or board eligible in Radiation Oncology.
  • Completion or near completion of a residency in ACGME accredited Radiation Oncology.

Nice To Haves

  • Experience in Head and Neck Oncology.
  • Interest in research and academic development.
  • Interest in teaching.

Responsibilities

  • Primary clinical focus in Head and Neck Oncology with a negotiable secondary focus.
  • Active participation in disease-specific multidisciplinary tumor boards.
  • Teaching opportunities within fully accredited medical and medical physics residency programs.
  • Potential for protected time for research and academic development.
  • Emphasis on work-life balance with favorable call schedules.

Benefits

  • Dual employment with generous compensation package.
  • Relocation assistance.
  • Access to state-of-the-art treatment facilities.
  • Access to advanced radiation therapy technologies.
  • Robust support from a highly skilled team of physicists and dosimetrists.
  • Supportive culture that values respect, collaboration, and professional growth.
  • Opportunity for variable compensation.
  • Research startup funding is negotiable.
  • Access to growing opportunities for grant funding.
  • On-site Mevion upright proton therapy opening in Spring 2027.
  • Favorable call schedules.
  • Potential for protected time for research and academic development.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service